Health Subcommittee, Energy and Commerce Committee
Introduced
In Committee
On Floor
Passed Chamber
Enacted
Medical Innovation Never Stops Act of 2019 This bill requires the Food and Drug Administration (FDA) to accept and review new medical device applications and associated user fees during a lapse in appropriations. Under current law, the FDA is prohibited from accepting new user fees and reviewing medical device submissions during an appropriations lapse.
Get AI-generated questions to help you understand this bill better
Timeline
Introduced in House
Referred to the House Committee on Energy and Commerce.
Referred to the Subcommittee on Health.
Introduced in House
Referred to the House Committee on Energy and Commerce.
Referred to the Subcommittee on Health.
Health
AppropriationsDepartment of Health and Human ServicesDrug safety, medical device, and laboratory regulationExecutive agency funding and structureLicensing and registrationsUser charges and fees
Medical Innovation Never Stops Act of 2019
USA116th CongressHR-1362| House
| Updated: 2/27/2019
Medical Innovation Never Stops Act of 2019 This bill requires the Food and Drug Administration (FDA) to accept and review new medical device applications and associated user fees during a lapse in appropriations. Under current law, the FDA is prohibited from accepting new user fees and reviewing medical device submissions during an appropriations lapse.
Health Subcommittee, Energy and Commerce Committee
Health
Introduced
In Committee
On Floor
Passed Chamber
Enacted
AppropriationsDepartment of Health and Human ServicesDrug safety, medical device, and laboratory regulationExecutive agency funding and structureLicensing and registrationsUser charges and fees